Study search
Go straight to the source
Search PubMed, Europe PMC and ClinicalTrials.gov from one box. Results come from the indexes themselves, newest first, each linked to its original record.
Amiravo's reviewed summary: Tesofensine research reference →
52 records · showing 25 · open this search in PubMed
- PubMedInvestigations Into the Metabolism and Elimination of Tesofensine in Human Urine.Drug testing and analysis · 2026 Sep
- PubMedStructural basis for pharmacotherapeutic action of triple reuptake inhibitors.Nature communications · 2025 Dec 14
- PubMedResearch Support, Non-U.S. Gov'tSex-specific effects of appetite suppressants on stereotypy in rats.PloS one · 2025
- PubMedResearch Support, Non-U.S. Gov'tTesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons.PloS one · 2024
- PubMedRandomized Controlled TrialRandomized controlled trial of Tesomet for weight loss in hypothalamic obesity.European journal of endocrinology · 2022 May 9
- PubMedReviewNew insights into potential nutritional effects of dietary saponins in protecting against the development of obesity.Food chemistry · 2020 Jul 15
- PubMedReviewAnorectic state of obesity medications in the United States. Are leaner times ahead?Expert opinion on pharmacotherapy · 2020 Feb
- PubMedReviewCentrally Acting Agents for Obesity: Past, Present, and Future.Drugs · 2018 Jul
- PubMedReviewFuture Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon.Current obesity reports · 2018 Jun
- PubMedResearch Support, Non-U.S. Gov'tReviewApproaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome.Current pharmaceutical design · 2016
- PubMedReviewThe many different faces of major depression: it is time for personalized medicine.European journal of pharmacology · 2015 Apr 15
- PubMedReviewDopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine.Neuropharmacology · 2014 Dec
- PubMedTesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PET.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2014 Feb
- PubMedComparative StudyReviewNew and emerging drug molecules against obesity.Journal of cardiovascular pharmacology and therapeutics · 2014 Jan
- PubMedResearch Support, Non-U.S. Gov'tTesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat.Pharmacology, biochemistry, and behavior · 2013 Sep
- PubMedSafety of antiobesity drugs.Therapeutic advances in drug safety · 2013 Aug
- PubMedLetterCommentUnder-reporting of adverse effects of tesofensine.Lancet (London, England) · 2013 Jul 13
- PubMedAnti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats.Obesity (Silver Spring, Md.) · 2013 May
- PubMedEditorialCommentExpression of ConcernExpression of concern--effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.Lancet (London, England) · 2013 Apr 6
- PubMedReviewAnti-obesity drugs: a review about their effects and their safety.Expert opinion on drug safety · 2012 May
- PubMedResearch Support, Non-U.S. Gov'tTriple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2012 Apr
- PubMedClinical Trial, Phase IIMulticenter StudyRandomized Controlled TrialThe effect of tesofensine on appetite sensations.Obesity (Silver Spring, Md.) · 2012 Mar
- PubMedReviewSerotonergic anti-obesity agents: past experience and future prospects.Drugs · 2011 Dec 3
- PubMedReviewNeuropsychiatric adverse effects of centrally acting antiobesity drugs.CNS neuroscience & therapeutics · 2011 Oct
- PubMedPharmacotherapies for obesity: past, current, and future therapies.Journal of obesity · 2011
Queries go directly from your browser to NCBI, EMBL-EBI and ClinicalTrials.gov; Amiravo does not store them. Study-type labels come from the indexes and can be wrong. A record's presence says nothing about whether a compound works or is safe. PubMed data via NCBI E-utilities; see NCBI policies.